Patrick Mahaffy, President & CEO, Director at Clovis Oncology, holds 970.79K shares in Clovis Oncology (Ticker: CLVSQ), holds 0.00 shares in Orexigen (Ticker: OREXQ), holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN). Most recently, Patrick Mahaffy Bought ― shares of Clovis Oncology on Aug 19, 2019 for an estimated value of 279.58K.